All Articles

As AI agents proliferate, a new class of threats emerges. The Cloud Security Alliance, with Rubrik, is launching a new center to build enterprise resilience.

As Sonida Senior Living prepares its Q2 results, investors are watching closely. Can the operator prove its massive merger is paying off amidst industry-wide cost pressures?

Cohen & Company's Q2 results showcase its mastery of the resurgent SPAC market. With revenue soaring to $69.5M and major deals inked, the boutique firm proves that specialized expertise can deliver outsized returns.

How a boutique airline used a historic baseball moment to cement its brand in L.A., celebrating Taiwanese pride and redefining corporate sponsorship.

As global baby gear giant Joie enters Canada, it's not just about strollers. It's a test of retail strategy, a challenge to safety standards, and a bold move in a multi-billion dollar market.

Guidewire's new Qusar release introduces an 'Agentic Framework,' moving AI from isolated experiments to the core of P&C operations. Is this the key to durable value?

Faced with impossible costs and AI anxiety, Gen Z and Millennials are delaying the American Dream. But they aren't giving up—they're rewriting the rules.

IT solutions provider Hitek Global is betting big on digital marketing with its $20M acquisition. Is this a savvy pivot or a costly diversification?

As Continual-G expands across the US with bold scientific claims, it highlights a growing trend and a critical question: is this the future of wellness, or just for the wealthy?

As Springboard Wine & Spirits elevates a new sales leader, a deeper look reveals a strategy where culture isn't just a buzzword—it's the core asset.

As global infrastructure crumbles, a new AI framework from South Korea uses drones and 3D models to predict failures, promising safer bridges and huge savings.

From Amazon retail to darknet intelligence, Nexera's LOI with Nebo signals a bold pivot. Can this bet on proactive data center security redefine its future?

A South Korean lab has cracked a key battery problem, promising safer, ultra-fast EV charging. But can this new anode design outpace global rivals?

Curium's landmark $8 billion acquisition of Lantheus is set to create a global powerhouse in nuclear medicine, reshaping patient care and the competitive landscape.

Enterprise AI leader Yellow.ai is going public via a SPAC merger, aiming to deploy autonomous agents and disrupt the massive $900 billion BPO industry.

A new defense tech player just landed a major Air Force deal. We go beyond the headlines to reveal the financial machinery and strategic plays driving it.

As Students 2 Science founder Dr. Paul Winslow steps back, the nonprofit signals a new growth phase by promoting a proven leader from within its own ranks.

Autolus Therapeutics reports a 100% year-over-year sales jump and a stunning gross margin reversal, securing a $250M credit facility to fund its next big move.

Biocon's Yesafili, an interchangeable biosimilar to the $5.9B eye drug Eylea, launches in the US, promising major cost savings and market disruption.

The German prosthetics giant just built its first US facility from scratch. It’s more than a clinic; it's a bet on transparency, community, and the 2028 Paralympics.